Intravenous tissue plasminogen activator for patients with minor ischemic stroke. - Wikidata - awgldk - TriplyDB

Intravenous tissue plasminogen activator for patients with minor ischemic stroke.

Intravenous tissue plasminogen activator for patients with minor ischemic stroke.

http://www.wikidata.org/entity/Q35190051

about

Minor Stroke and Transient Ischemic Attack: Research and Practice Magnetic Resonance Imaging in Acute Ischemic Stroke Patients with Mild Symptoms: An Opportunity to Standardize Intravenous Thrombolysis Safety and outcome of thrombolysis in mild stroke: a meta-analysis.Intravenous thrombolysis for minor stroke and rapidly improving symptoms: a quantitative overview.Should minor stroke patients be thrombolyzed? A focused review and future directions.A Retrospective Study of thrombolysis with 0.6 mg/kg Recombinant Tissue Plasminogen Activator (rt-PA) in Mild Stroke.Efficacy and safety of intravenous recombinant tissue plasminogen activator in mild ischaemic stroke: a meta-analysis.

P2860

Q26745201-FDF0CFB3-0409-4160-B838-381E0A07C54A Q30956240-FB7E94E6-1284-45AA-AEA2-12770EE18548 Q34496025-394DDF0A-2B20-4AD5-8433-A063ECE4EE70 Q38234091-C8670574-391A-4015-B76E-FC798B602570 Q38302755-5FC606DE-46E6-4DCA-97F5-10787E94C586 Q39502448-D6CC61FF-B75F-4D86-902F-6D7D932CB372 Q52620337-EA36A366-4230-43D3-9F94-65812F90C716

P2860

Intravenous tissue plasminogen activator for patients with minor ischemic stroke.

http://www.wikidata.org/entity/Q35190051

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Intravenous tissue plasminogen activator for patients with minor ischemic stroke.

@ast

Intravenous tissue plasminogen activator for patients with minor ischemic stroke.

@en

type

label

Intravenous tissue plasminogen activator for patients with minor ischemic stroke.

@ast

Intravenous tissue plasminogen activator for patients with minor ischemic stroke.

@en

prefLabel

Intravenous tissue plasminogen activator for patients with minor ischemic stroke.

@ast

Intravenous tissue plasminogen activator for patients with minor ischemic stroke.

@en

P1433

Q35190051-F67BA25B-348E-4777-AAB4-0047FC0F3A56

P1476

Q35190051-4BE365E5-D289-445C-B471-964F9576A79C

P2093

Q35190051-3FEC9BA1-29D7-411E-B56F-F74029CC7898

Q35190051-9C729E22-5045-450D-AE16-95EC1321A1B2

Q35190051-9C788B45-FAA4-45B7-8418-6C86138113C7

Q35190051-9FB56C68-228A-4556-8DA7-EE6769CA8BE0

Q35190051-CE0E0FF0-B377-4767-A657-4FF3615B214E

P2860

Q35190051-1000B745-DC2B-4FE7-BA27-C397E62BE517

Q35190051-116A80DA-B7E3-4CBD-AD75-A5D214A71ECF

Q35190051-1306170D-CE6E-4238-BF32-A4B3026ACC96

Q35190051-17910229-626C-48D4-B2E8-AB2EB747BAC9

Q35190051-326AE600-5418-42D5-916D-9C113E773C95

Q35190051-3FA625B2-6687-4D35-B0A6-9757D4794B87

Q35190051-60F000C8-481C-44E0-9E22-860A296E6CEA

Q35190051-6619840E-5690-412A-BED8-D4C04DF48772

Q35190051-6881A5E7-88A8-410D-B632-43D209FD352F

Q35190051-B7588533-6BF0-47E6-98BD-2C723DDE240D

P304

Q35190051-D11AE78A-9241-4D95-8F30-9A8A882C472A

P31

Q35190051-2FAAA565-FE2D-4670-BBBC-4D7CE2623785

P356

Q35190051-AB173E33-6639-41AD-8C60-C8DFCAD54C11

P433

Q35190051-358F554C-A30B-49D1-88F9-9BAFE5C928AD

P478

Q35190051-029EC932-215B-4D0E-87B7-F3C863A7FF92

P577

Q35190051-B6B52CF1-2EFE-4457-ACF7-DE00AF8E6261

P698

Q35190051-A9F1D715-C1D8-4357-BED7-097D58D9F713

P932

Q35190051-DC9EAB2D-0A7C-4C0D-9CDA-8FA5265E09E5

P356

J.JSTROKECEREBROVASDIS.2011.03.009

P1433

Journal of Stroke and Cerebrovascular Diseases

P1476

Intravenous tissue plasminogen activator for patients with minor ischemic stroke.

@en

P2093

Branko N Huisa

http://www.w3.org/2001/XMLSchema#string

Karin Ernstrom

http://www.w3.org/2001/XMLSchema#string

Rema Raman

http://www.w3.org/2001/XMLSchema#string

Thomas M Hemmen

http://www.w3.org/2001/XMLSchema#string

Will Neil

http://www.w3.org/2001/XMLSchema#string

P2860

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

Tissue plasminogen activator for acute ischemic stroke

Thrombolysis is associated with consistent functional improvement across baseline stroke severity: a comparison of outcomes in patients from the Virtual International Stroke Trials Archive (VISTA).

Zero on the NIHSS does not equal the absence of stroke.

Safety and outcome after thrombolysis in stroke patients with mild symptoms.

Thrombolysis targeting MRI defined tissue at risk in minor stroke.

Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study.

Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group.

Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility.

Reasons for exclusion from thrombolytic therapy following acute ischemic stroke.

P304

732-736

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JSTROKECEREBROVASDIS.2011.03.009

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21531576

http://www.w3.org/2001/XMLSchema#string

P932

3164904

http://www.w3.org/2001/XMLSchema#string